- Home
- SABS vs YYAI Comparison
SABS vs YYAI Comparison
Compare SABS & YYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- YYAI
- Stock Information
- Founded
- SABS 2014
- YYAI 2015
- Country
- SABS United States
- YYAI United States
- Employees
- SABS N/A
- YYAI N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- YYAI
- Sector
- SABS Health Care
- YYAI
- Exchange
- SABS Nasdaq
- YYAI NYSE
- Market Cap
- SABS 23.9M
- YYAI 19.5M
- IPO Year
- SABS N/A
- YYAI N/A
- Fundamental
- Price
- SABS $2.76
- YYAI $5.57
- Analyst Decision
- SABS Strong Buy
- YYAI
- Analyst Count
- SABS 5
- YYAI 0
- Target Price
- SABS $12.40
- YYAI N/A
- AVG Volume (30 Days)
- SABS 112.4K
- YYAI 164.3K
- Earning Date
- SABS 11-11-2024
- YYAI 11-26-2024
- Dividend Yield
- SABS N/A
- YYAI N/A
- EPS Growth
- SABS N/A
- YYAI N/A
- EPS
- SABS N/A
- YYAI N/A
- Revenue
- SABS $2,780,084.00
- YYAI $5,982,717.00
- Revenue This Year
- SABS N/A
- YYAI N/A
- Revenue Next Year
- SABS N/A
- YYAI N/A
- P/E Ratio
- SABS N/A
- YYAI N/A
- Revenue Growth
- SABS N/A
- YYAI N/A
- 52 Week Low
- SABS $2.16
- YYAI $2.90
- 52 Week High
- SABS $10.50
- YYAI $53.00
- Technical
- Relative Strength Index (RSI)
- SABS 51.65
- YYAI 42.91
- Support Level
- SABS $2.36
- YYAI $3.71
- Resistance Level
- SABS $3.21
- YYAI $9.85
- Average True Range (ATR)
- SABS 0.24
- YYAI 1.67
- MACD
- SABS 0.02
- YYAI -0.17
- Stochastic Oscillator
- SABS 47.06
- YYAI 28.22
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About YYAI CONNEXA SPORTS TECHNOLOGIES IN
Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.